Imagine reducing the time to identify a drug that shows results in the clinic to five years: this proof-of-concept study shows how
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Sat Mar 04 2023 01:56:32 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
Patients with mutated KRAS (Kirsten rat sarcoma virus) gene account for around 30-50% of the population with colorectal cancer (CRC) and do not respond to cetuximab, a recognized choice of antibody therapy. A new proof-of-concept study led by the SuppresSTEM European consortium discovers a bispecific antibody that prevents the onset of metastasis and sedates the […] The post Imagine reducing the t
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。